| Literature DB >> 31842311 |
Elizaveta S Permyakova1, Philipp V Kiryukhantsev-Korneev1, Kristina Yu Gudz1, Anton S Konopatsky1, Josef Polčak2,3, Irina Y Zhitnyak4, Natalia A Gloushankova4, D V Shtansky1, Anton M Manakhov5.
Abstract
Due to their good mechanical stability compared to gelatin, collagen or polyethylene glycol nanofibers and slow degradation rate, biodegradable poly-ε-caprolactone (PCL) nanofibers are promising material as scaffolds for bone and soft-tissue engineering. Here, PCL nanofibers were prepared by the electrospinning method and then subjected to surface functionalization aimed at improving their biocompatibility and bioactivity. For surface modification, two approaches were used: (i) COOH-containing polymer was deposited on the PCL surface using atmospheric pressure plasma copolymerization of CO2 and C2H4, and (ii) PCL nanofibers were coated with multifunctional bioactive nanostructured TiCaPCON film by magnetron sputtering of TiC-CaO-Ti3POx target. To evaluate bone regeneration ability in vitro, the surface-modified PCL nanofibers were immersed in simulated body fluid (SBF, 1×) for 21 days. The results obtained indicate different osteoblastic and epithelial cell response depending on the modification method. The TiCaPCON-coated PCL nanofibers exhibited enhanced adhesion and proliferation of MC3T3-E1 cells, promoted the formation of Ca-based mineralized layer in SBF and, therefore, can be considered as promising material for bone tissue regeneration. The PCL-COOH nanofibers demonstrated improved adhesion and proliferation of IAR-2 cells, which shows their high potential for skin reparation and wound dressing.Entities:
Keywords: XPS; mineralization; plasma modification; polycaprolactone nanofibers; tissue engineering
Year: 2019 PMID: 31842311 PMCID: PMC6955782 DOI: 10.3390/nano9121769
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Scanning electron microscope (SEM) images of poly-ε-caprolactone (PCL)-ref, PCL–COOH, and PCL–TiCaPCON nanofibers before (left column) and after biomimetic mineralization for 1, 3, 7 and 14 days.
Figure 2Atomic force microscopy (AFM) images of PCL-ref (A), PCL–TiCaPCON (B), PCL–COOH (C), PCL-ref-SBF-72h (D), PCL–COOH-SBF-72h (E), and PCL–TiCaPCON-SBF-72h (F,G) samples.
Figure 3XPS C1s spectra of as-prepared nanofibers (a–c) and those after immersion in simulated body fluid (SBF) for 12 (d) and 72 h (e). PCL-ref (a), PCL–TiCaPCON (b), and PCL–COOH (c–e).
Figure 4Water contact angle of PCL-ref (A), PCL–COOH (B) and PCL–TiCaPCON (C).
Atomic percentages of the elements determined by X-ray photoelectron spectroscopy (XPS) analysis.
| Sample Name | (C), at.% | (O), at.% | (N), at.% | (Ca), at.% | (Na), at.% | (Ti), at.% |
|---|---|---|---|---|---|---|
| PCL-ref | 76.0 | 24.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| PCL–TiCaPCON | 55.4 | 22.5 | 8.6 | 1.1 | 0.0 | 8.4 |
| PCL–COOH | 77.0 | 23.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| PCL–COOH-12h | 75.0 | 22.0 | 1.1 | 1.5 | 0.4 | 0.0 |
| PCL–COOH-24h | 77.3 | 20.1 | 1.0 | 1.2 | 0.3 | 0.0 |
| PCL–COOH-72h | 78.2 | 18.4 | 2.4 | 1.0 | 0.0 | 0.0 |
Figure 5The concentration of Ca as a function of immersion time in SBF.
Figure 6Attenuated total reflection–Fourier transform infrared (ATR–FTIR) spectra of PCL, PCL–COOH, and PCL–TiCaPCON before (A) and after immersion in SBF (B–D).
Figure 7The fluorescence microscopy images showing the actin cytoskeleton and focal adhesions of IAR-2 (a) and MC3T3-E1 (b) cells on the surface of tested samples. Staining for F-actin (green) and paxillin (red). Bar is 10 μm.
Figure 8Proliferation and spreading of IAR-2 (A) and MC3T3-E1 (B) cells on the surfaces of tested samples. *—p < 0.05, ***—p < 0.001, ****—p < 0.0001.
The effect of mineralization method on the cell/nanofiber interaction.
| Nanofiber Chemical Composition | Mineralization Method | Cell Type | Cell/Material Interaction | Reference |
|---|---|---|---|---|
| PCL/gelatin, PCL/gelatin/nano–hydroxyapatite (HA) | nano-HA-doped electrospun solution | DPSCs | Cell attachment and growth was not improved | [ |
| PCL–COOH PCL–COOH-SBF | SBF solution | hASCs | Improved osteogenic differentiation of SBF-treated samples | [ |
| PLA PLA/Ca3(PO4)2 PLA/Ca3(PO4)2/BSA | SBF-solution, deposition of amorphous Ca3(PO4)2 film | MG-63 | No significant differences for cell adhesion and spreading | [ |
| PLA/TSF, PLA/TSF/HA | 1.5× SBF doped with 1 wt% of asparaginic acid | MSCs | Improved cell proliferation and differentiation on the PLA/TSF/HA | [ |
| PLGA, PLGA–COOH, PLGA–COOH-Glu6 | 1.5× SBF | hMSCs | Improved proliferation | [ |
| PCL/nano–HA PCL/nano–HA–COOH | nano-HAp-doped electrospun solution | MC3T3-E1 | Enhanced attachment, proliferation, and differentiation | [ |
| PCL, PCL–COOH PCL–COOH/PRP | - | MRC-5 | The number of adhered cells did not differ significantly. More uniform cell distribution on the surface of PCL–COOH | [ |
| PLGA (control), PLGA/HA PLGA/HA/ Dexamethasone | nano-HA-doped electrospun solution | MC3T3-E1 | Slow cell proliferation compared with control | [ |
| PLLA/PCL | Electrochemical deposition | rBMSCs | enhanced the osteogenic differen- tiation and proliferation of rBMSCs for treated sample | [ |
| BR or G-BR nanoparticles into PHBV nanofibers | Electrochemical deposition | hFOB | Enhanced cell proliferation | [ |
Dental pulp stem cells (DPSCs), human adipose derived stem cells (hASCs), mesenchemal stem cells (MSCs), rate bone MSCs (rBMSCs), human fetal osteoblastic cells (hFOB).